Apellis Pharmaceuticals, Inc. (APLS)

NASDAQ: APLS · Real-Time Price · USD

17.43

-0.97 (-5.27%)

At close: Jun 27, 2025, 4:00 PM

17.78

+0.35 (2.01%)

After-hours: Jun 27, 2025, 7:49 PM EDT

Apellis Pharmaceuticals Market Cap

Apellis Pharmaceuticals has a market cap or net worth of $2.19 billion as of June 27, 2025. Its market cap has decreased by -57.78% in one year.

Market Cap

2.19B

Enterprise Value

2.30B

1-Year Change

-57.78%

Ranking

#1867

Market Cap Chart

Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from $691.07M to $2.19B, an increase of 216.99%. That is a compound annual growth rate of 16.31%.

Market Cap History

Date	Market Cap	% Change
Jun 27, 2025	2.19B	-44.81%
Dec 31, 2024	3.97B	-44.04%
Dec 29, 2023	7.09B	24.06%
Dec 30, 2022	5.72B	24.22%
Dec 31, 2021	4.60B	6.25%
Dec 31, 2020	4.33B	121.45%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	714.15B
Johnson & Johnson	366.81B
AbbVie	329.12B
Novo Nordisk	301.06B
UnitedHealth Group	275.01B
Abbott Laboratories	232.56B
Novartis AG	231.01B
AstraZeneca	216.45B

Market Cap Rankings